Canadian General Medical Center Complex Company
TADAWUL:9518.SR
6.9 (SAR) • At close June 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 59.578 | 51.224 | 55.125 | 45.217 | 42.313 | 38.917 | 40.459 | 30.183 | 34.384 | 29.832 | 26.779 | 26.779 |
| Cost of Revenue
| 42.643 | 39.714 | 37.796 | 31.005 | 29.969 | 26.288 | 27.659 | 17.791 | 21.408 | 17.609 | 16.278 | 16.278 |
| Gross Profit
| 16.936 | 11.51 | 17.329 | 14.212 | 12.343 | 12.629 | 12.8 | 12.393 | 12.975 | 12.223 | 10.501 | 10.501 |
| Gross Profit Ratio
| 0.284 | 0.225 | 0.314 | 0.314 | 0.292 | 0.325 | 0.316 | 0.411 | 0.377 | 0.41 | 0.392 | 0.392 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 5.375 | 0.676 | 2.953 | 1.725 | 1.758 | 1.624 | 2.944 | 1.616 | 1.752 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 1.84 | 0.923 | 2.953 | 3.152 | 1.758 | 1.381 | 2.944 | 2.918 | 1.752 | 0 | 0 |
| SG&A
| 9.149 | 7.632 | 3.268 | 5.906 | 4.198 | 3.516 | 3.004 | 5.888 | 4.534 | 3.503 | 2.352 | 2.352 |
| Other Expenses
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 9.149 | 7.632 | 3.268 | 5.906 | 4.198 | 3.516 | 3.004 | 5.888 | 4.534 | 3.503 | 2.352 | 2.352 |
| Operating Income
| 7.787 | 3.878 | 14.06 | 8.306 | 8.145 | 9.112 | 9.796 | 6.505 | 8.442 | 8.72 | 8.149 | 8.149 |
| Operating Income Ratio
| 0.131 | 0.076 | 0.255 | 0.184 | 0.192 | 0.234 | 0.242 | 0.216 | 0.246 | 0.292 | 0.304 | 0.304 |
| Total Other Income Expenses Net
| 0.256 | 0.973 | -5.371 | 0.866 | 0.639 | 0.075 | 0.409 | -0.181 | -0.384 | -0.066 | -0.51 | -0.51 |
| Income Before Tax
| 8.043 | 4.851 | 8.689 | 9.173 | 8.784 | 9.188 | 10.205 | 6.324 | 8.057 | 8.654 | 7.639 | 7.639 |
| Income Before Tax Ratio
| 0.135 | 0.095 | 0.158 | 0.203 | 0.208 | 0.236 | 0.252 | 0.21 | 0.234 | 0.29 | 0.285 | 0.285 |
| Income Tax Expense
| 1.144 | 1.482 | 0.98 | 1.172 | 1.068 | 1.25 | 1.104 | 1.361 | 0.303 | 0.255 | 0.202 | 0.202 |
| Net Income
| 6.899 | 3.37 | 7.709 | 8.001 | 7.716 | 7.938 | 9.101 | 4.963 | 7.754 | 8.399 | 7.437 | 7.437 |
| Net Income Ratio
| 0.116 | 0.066 | 0.14 | 0.177 | 0.182 | 0.204 | 0.225 | 0.164 | 0.226 | 0.282 | 0.278 | 0.278 |
| EPS
| 0.09 | 0.044 | 0.1 | 0.1 | 0.1 | 0.1 | 0.12 | 0.065 | 0.1 | 83.99 | 74.37 | 74.37 |
| EPS Diluted
| 0.09 | 0.044 | 0.1 | 0.1 | 0.1 | 0.1 | 0.12 | 0.065 | 0.1 | 83.99 | 74.37 | 74.37 |
| EBITDA
| 10.709 | 4.872 | 16.022 | 9.501 | 10.879 | 10.736 | 11.989 | 8.01 | 10.241 | 10.108 | 8.8 | 8.8 |
| EBITDA Ratio
| 0.18 | 0.095 | 0.291 | 0.21 | 0.257 | 0.276 | 0.296 | 0.265 | 0.298 | 0.339 | 0.329 | 0.329 |